Split crRNA-Mediated Regulation of CRISPR-Cas12a Enables Construction of Biochemical Circuits for Sensitive Molecular Diagnostics
Analytical Chemistry · 05.08.2025 · 97 (30) · 16645-16651
DOI: 10.1021/acs.analchem.5c03196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 21.07.2025. Verfasst von Xiaoning Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, South-Central Minzu University, Wuhan 430074, P. R. China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, CRISPR-Associated Proteins, Endodeoxyribonucleases, RNA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: South-Central University for Nationalities, Natural Science Foundation of Hubei Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The clustered regularly interspaced short palindromic repeat (CRISPR) system represents a fundamental tool for biotechnological applications. However, the ability to engineer intrinsic components of the CRISPR system to regulate its activity remains limited. Here, we present a strategy for the regulation of CRISPR-Cas12a by engineering an enhanced split CRISPR RNA (split en-crRNA) variant. Reassembly of this variant autonomously restores the full activity of Cas12a nuclease without the need for chemical modifications or exogenous activation stimuli. Leveraging this strategy, we developed CREST (CRISPR Reactions Elicited by Split en-crRNA Transcription) for molecular diagnostics. CREST integrates biochemical circuits that ingeniously harness isothermal amplification to trigger the on-demand synthesis and reassembly of a universal split en-crRNA, addressing longstanding challenges in CRISPR diagnostics, including the low efficiency of one-pot assays, protospacer adjacent motif restriction, the need for crRNA reoptimization, and limited reagent stability. The CREST assay enables robust detection of attomolar DNAs or RNAs within 15 to 20 min and demonstrates capability for identifying bacterial infections in patients. This study provides new insights into Cas12a regulation, which is expected to advance the development of controllable CRISPR technologies for diagnostics as well as broader applications such as genome editing and programmable gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, South-Central Minzu University, Wuhan 430074, P. R. China.
- Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine, Wuhan 430061, P. R. China.
- School of Public Health, Guilin Medical University, Guilin 541199, P. R. China.
- Hubei Jiangxia Laboratory, Wuhan 430200, P. R. China.
ORCID-Profile: Yong Li
Förderung
- South-Central University for Nationalities
- Natural Science Foundation of Hubei Province
- National Natural Science Foundation of China
Zitieren
APA
Xu, X., Tang, K., Yang, L., Wu, Y., Gu, Y., & Li, Y. (2025). Split crRNA-Mediated Regulation of CRISPR-Cas12a Enables Construction of Biochemical Circuits for Sensitive Molecular Diagnostics. Analytical Chemistry, 97(30), 16645-16651. https://doi.org/10.1021/acs.analchem.5c03196
Vancouver
Xu X, Tang K, Yang L, Wu Y, Gu Y, Li Y. Split crRNA-Mediated Regulation of CRISPR-Cas12a Enables Construction of Biochemical Circuits for Sensitive Molecular Diagnostics. Analytical Chemistry. 2025;97(30):16645-16651. doi:10.1021/acs.analchem.5c03196
BibTeX
@article{Xu2025,
author = {Xu, Xiaoning and Tang, Ke and Yang, Liu and Wu, Yunhua and Gu, Yiping and Li, Yong},
title = {Split crRNA-Mediated Regulation of CRISPR-Cas12a Enables Construction of Biochemical Circuits for Sensitive Molecular Diagnostics},
journal = {Analytical Chemistry},
year = {2025},
volume = {97},
number = {30},
pages = {16645--16651},
doi = {10.1021/acs.analchem.5c03196}
}
EUVIMED